Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has filed a complaint at the United States International Trade Commission (ITC) against Nanomics Biotechnology Co., Ltd. The Brigham and Women’s Hospital […]
Seer defends its pioneering Proteograph® Product Suite intellectual property (IP) REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has filed a patent infringement suit against Nanomics Biotechnology Co., Ltd. The asserted patents, U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590,948, protect […]
ATLANTA, GA — Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the issues in the two lawsuits between them, pending in the United States District Court for the District of Delaware, pursuant to the terms of a confidential settlement agreement. Neither […]
REDWOOD CITY, Calif. — Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc., effectively concluding a multi-year legal challenge and solidifying the invalidation of two Agilent CRISPR-related patents that claimed a widely used […]
US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 SCHLIEREN, Switzerland & MUNICH — PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024‑01473 before the U.S. Patent Trial and Appeal Board (PTAB). The PTAB has revoked the central claims of U.S. Patent […]
23 claims of U.S. Patent No. 11,435,360 remain valid, supporting Seer’s Proteograph® Product Suite REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a leader in deep, unbiased proteomic insights, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office issued a Final Written Decision on March 23, 2026, […]
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced that it has entered into a settlement and patent license agreement with Bruker Corporation, resolving the patent litigation between the two companies globally. As part of the settlement, Bruker will pay AbCellera $36 million up front as well as future royalty payments on sales of Bruker’s Beacon® Optofluidic […]
CAMBRIDGE, England – biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (“Watchmaker”) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ […]
TeraView is pleased to announce a newly granted US patent that covers a pioneering test system designed for devices with multiple electrical contacts, integrating a movable probe assembly and a sophisticated profile-determining system. This system ensures precise mapping and reliable testing of advanced 2.5/3D packaging used in chips for artificial intelligence (AI), machine learning as well […]
SAN DIEGO — The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases. Illumina remains focused […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
